From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster ...

An immunotherapy treatment has been found to ‘change the world’ for head and neck cancer patients by giving them an extra two ...

Abpro Holdings (ABP) and Celltrion unveiled preclinical data for ABP-102/CT-P72 in an oral presentation at the American Association for Cancer ...

Join Drs Maureen McMahon and Michael Garshick as they discuss cardiovascular disease in patients with systemic lupus erythematosus, focusing on hidden risk and challenging clinical scenarios.

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., ...

A study published in the American Journal of Obstetrics & Gynecology by researchers at Baylor College of Medicine, UTHealth ...

Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data ...

Uncover the gut health benefits of fermented foods like sauerkraut, protecting intestinal cells from inflammation damage.

The regenerative role of the adult stem cell secretome is a burgeoning area of research with significant therapeutic potential. These secretomes, which include a variety of growth factors, cytokines, ...

Fermented cabbage metabolites play a crucial role in maintaining gut barrier function, suggesting potential health benefits ...

A Q&A between Shawn Kwatra, M.D., professor and chair of dermatology at the University of Maryland School of Medicine, and Managed Healthcare Executive about new discoveries in chronic itch, how ...